Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

72
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
72
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

71
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
71
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

74
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
74
Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

176
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
176
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

82
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
82

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PERFECTA Loaded Lipid Cubosomes for <sup>19</sup>F-MRI: Physico-Chemical Characterization.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026
Same author

Announcement for JCIS.

Journal of colloid and interface science·2026
Same author

Electrochemical Impedance Spectroscopy Study of Water Uptake during the Removal of Polymer Coatings on Artworks.

Langmuir : the ACS journal of surfaces and colloids·2026
Same author

Development of Fully Green Castor Oil-Based Gels for Cultural Heritage Preservation.

Langmuir : the ACS journal of surfaces and colloids·2026
Same author

Multiphasic lipid nanoparticles: structural heterogeneity drives endosomal bypass for enhanced RNA delivery.

Journal of colloid and interface science·2026
Same author

Ethanol-Guided Hybridization of Extracellular Vesicles with Liquid-Crystalline Lipid Nanoparticles.

ACS applied materials & interfaces·2026
Same journal

Vertically Stacked Indium Gallium Zinc Oxide-Based Three-Dimensional Integrated Circuits.

ACS nano·2026
Same journal

Tunable Nanoparticle Thin-Film Reveals Distance Dependence of Auger-Mediated Radiation Enhancement in Diffuse Midline Glioma.

ACS nano·2026
Same journal

G-Quadruplex Network Engineering in Ionogels: Realizing Robust Biosensing Interfaces for Plant Electrophysiology.

ACS nano·2026
Same journal

Announcing the 2026 <i>ACS Nano</i> Lectureship and <i>ACS Nano</i> Impact Award Laureates.

ACS nano·2026
Same journal

Ultrafast Self-Assembly of Zeolitic Imidazolate Framework-8 Enables Antibody Orientation for Ultrasensitive Lateral Flow Immunoassays.

ACS nano·2026
Same journal

Interfacial Salt Engineering with Alkali and Ammonium Additives for Stable Pure-Blue Perovskite Light-Emitting Diodes and Micropatterned Displays.

ACS nano·2026
See all related articles

Related Experiment Video

Updated: Mar 16, 2026

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
09:11

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Published on: February 13, 2016

10.4K

Multifunctional Magnetoliposomes for Sequential Controlled Release.

Annalisa Salvatore1, Costanza Montis1, Debora Berti1

  • 1Department of Chemistry and CSGI, University of Florence , Via della Lastruccia 3, 50019-Sesto Fiorentino, Florence, Italy.

ACS Nano
|August 10, 2016
PubMed
Summary
This summary is machine-generated.

This study introduces a novel, self-assembled drug delivery system (DDS) using liposomes, DNA, and magnetic nanoparticles. This system allows controlled release of therapeutics triggered by magnetic fields, overcoming nanomedicine delivery challenges.

Keywords:
DNA deliverySPIONsantisense oligonucleotidescontrolled releasecore−shell NPsfluorescence correlation spectroscopymagnetoliposomes

More Related Videos

Magnetic and Thermal-sensitive PolyN-isopropylacrylamide-based Microgels for Magnetically Triggered Controlled Release
08:39

Magnetic and Thermal-sensitive PolyN-isopropylacrylamide-based Microgels for Magnetically Triggered Controlled Release

Published on: July 4, 2017

9.5K
Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes
09:51

Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes

Published on: March 3, 2020

10.0K

Related Experiment Videos

Last Updated: Mar 16, 2026

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
09:11

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Published on: February 13, 2016

10.4K
Magnetic and Thermal-sensitive PolyN-isopropylacrylamide-based Microgels for Magnetically Triggered Controlled Release
08:39

Magnetic and Thermal-sensitive PolyN-isopropylacrylamide-based Microgels for Magnetically Triggered Controlled Release

Published on: July 4, 2017

9.5K
Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes
09:51

Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes

Published on: March 3, 2020

10.0K

Area of Science:

  • Nanomedicine
  • Biomaterials Science
  • Supramolecular Chemistry

Background:

  • Developing effective drug delivery systems (DDS) for simultaneous or sequential delivery of multiple therapeutics to specific targets remains a significant challenge in nanomedicine.
  • Complex DDS often require time-consuming and costly construction.
  • Supramolecular self-assembly offers a facile synthetic route with high tunability and structural control for complex nanostructures.

Purpose of the Study:

  • To demonstrate the proof-of-principle for a multifunctional DDS based on supramolecular self-assembly.
  • To create a biocompatible DDS capable of controlled, triggered release of therapeutic payloads.

Main Methods:

  • Construction of a DDS comprising liposomes, cholesterol-conjugated double-stranded DNA, and hydrophobic/hydrophilic superparamagnetic iron oxide nanoparticles (SPIONs).
  • Embedding SPIONs within liposome membranes or conjugating them to DNA.
  • Utilizing alternating magnetic fields to trigger payload release via thermal activation of SPIONs.

Main Results:

  • The DDS successfully integrated liposomes, DNA, and SPIONs through self-assembly.
  • Application of alternating magnetic fields induced triggered release of DNA or liposomal payload.
  • Release kinetics were controllable by adjusting magnetic field frequency and application time, confirmed by fluorescence studies.
  • Differential localization of SPIONs dictated the release mechanism.

Conclusions:

  • This study validates a novel, self-assembled, multifunctional DDS.
  • The system leverages biocompatible building blocks and magnetic field-triggered release for controlled therapeutic delivery.
  • This approach offers a promising, tunable, and potentially cost-effective strategy for advanced nanomedicine applications.